MNKD
MANNKIND CORP
Overview
MANNKIND CORP is a Healthcare company operating in Biotechnology with a $1.20B market cap.
Most recent reported earnings: Q2 FY2026 (Aug 4, 2026).
21 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Management language signature
Disclosures
Investor Relations
Extracted from Unknown source, 2026-06-21.
Transcripts
Recent earnings calls
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
- Q1 FY2026Earnings2026-05-0610 Q&A exchanges
- Q4 FY2025Earnings2026-02-267 Q&A exchanges
- Q3 FY2025Earnings2025-11-0519 Q&A exchanges
- Q2 FY2025Earnings2025-08-0612 Q&A exchanges
- Q1 FY2025Earnings2025-05-0818 Q&A exchanges
- Q4 FY2024Earnings2025-02-2611 Q&A exchanges
- Q3 FY2024Earnings2024-11-0713 Q&A exchanges
- Q2 FY2024Earnings2024-08-079 Q&A exchanges
- Q1 FY2024Earnings2024-05-087 Q&A exchanges
- Q4 FY2023Earnings2024-02-2719 Q&A exchanges
- Q3 FY2023Earnings2023-11-0713 Q&A exchanges
- Q2 FY2023Earnings2023-08-0821 Q&A exchanges
- Q1 FY2023Earnings2023-05-0921 Q&A exchanges
- Q4 FY2022Earnings2023-02-2411 Q&A exchanges
- Q3 FY2022Earnings2022-11-0810 Q&A exchanges
- Q2 FY2022Earnings2022-08-097 Q&A exchanges
- Q1 FY2022Earnings2022-05-0515 Q&A exchanges
- Q4 FY2021Earnings2022-02-2411 Q&A exchanges
- Q3 FY2021Earnings2021-11-093 Q&A exchanges
- Q2 FY2021Earnings2021-08-1116 Q&A exchanges
- Q1 FY2021Earnings2021-05-1310 Q&A exchanges
History
Earnings history
- Q2 FY20262026-08-04EPS— vs $0.01—Rev— vs ——EODHD
- Q1 FY20262026-05-06EPS$-0.02 vs $0.01-100.0%Rev$90.2M vs ——EODHD
- Q4 FY20252026-03-02EPS$0.01 vs $0.02-52.6%Rev$112.0M vs ——EODHD
- Q3 FY20252025-11-04EPS$0.07 vs $0.02+100.0%Rev$82.1M vs ——EODHD
- Q2 FY20252025-08-05EPS$0.05 vs $0.050.0%Rev$76.5M vs ——EODHD
- Q1 FY20252025-05-05EPS$0.04 vs $0.06-33.3%Rev$78.4M vs ——EODHD
- Q4 FY20242025-02-24EPS$0.03 vs $0.03-15.0%Rev$76.8M vs ——EODHD
- Q3 FY20242024-11-06EPS$0.05 vs $0.03+66.7%Rev$70.1M vs ——EODHD
- Q2 FY20242024-08-06EPS$-0.01 vs $0.01-100.0%Rev$72.4M vs ——EODHD
- Q1 FY20242024-05-07EPS$0.04 vs $0.03+33.3%Rev$66.3M vs ——EODHD
- Q4 FY20232024-02-26EPS$0.00 vs $0.01-57.0%Rev$58.5M vs ——EODHD
- Q3 FY20232023-11-06EPS$0.01 vs $-0.02+100.0%Rev$51.3M vs ——EODHD
- Q2 FY20232023-08-06EPS$-0.02 vs $-0.04+50.0%Rev$48.6M vs ——EODHD
- Q1 FY20232023-05-08EPS$-0.04 vs $-0.05+20.0%Rev$40.6M vs ——EODHD
- Q4 FY20222023-02-21EPS$-0.07 vs $-0.06-16.7%Rev$36.1M vs ——EODHD
- Q3 FY20222022-11-07EPS$-0.06 vs $-0.09+33.3%Rev$32.8M vs ——EODHD
- Q2 FY20222022-08-08EPS$-0.11 vs $-0.09-22.2%Rev$18.9M vs ——EODHD
- Q1 FY20222022-05-04EPS$-0.10 vs $-0.100.0%Rev$12.0M vs ——EODHD
- Q4 FY20212022-02-23EPS$-0.11 vs $-0.07-57.1%Rev$12.5M vs ——EODHD
- Q3 FY20212021-11-08EPS$-0.02 vs $-0.07+71.4%Rev$22.2M vs ——EODHD
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q2 FY2026 | 2026-08-04 | — | $0.01 | — | — | — | — | EODHD |
| Q1 FY2026 | 2026-05-06 | $-0.02 | $0.01 | -100.0% | $90.2M | — | — | EODHD |
| Q4 FY2025 | 2026-03-02 | $0.01 | $0.02 | -52.6% | $112.0M | — | — | EODHD |
| Q3 FY2025 | 2025-11-04 | $0.07 | $0.02 | +100.0% | $82.1M | — | — | EODHD |
| Q2 FY2025 | 2025-08-05 | $0.05 | $0.05 | 0.0% | $76.5M | — | — | EODHD |
| Q1 FY2025 | 2025-05-05 | $0.04 | $0.06 | -33.3% | $78.4M | — | — | EODHD |
| Q4 FY2024 | 2025-02-24 | $0.03 | $0.03 | -15.0% | $76.8M | — | — | EODHD |
| Q3 FY2024 | 2024-11-06 | $0.05 | $0.03 | +66.7% | $70.1M | — | — | EODHD |
| Q2 FY2024 | 2024-08-06 | $-0.01 | $0.01 | -100.0% | $72.4M | — | — | EODHD |
| Q1 FY2024 | 2024-05-07 | $0.04 | $0.03 | +33.3% | $66.3M | — | — | EODHD |
| Q4 FY2023 | 2024-02-26 | $0.00 | $0.01 | -57.0% | $58.5M | — | — | EODHD |
| Q3 FY2023 | 2023-11-06 | $0.01 | $-0.02 | +100.0% | $51.3M | — | — | EODHD |
| Q2 FY2023 | 2023-08-06 | $-0.02 | $-0.04 | +50.0% | $48.6M | — | — | EODHD |
| Q1 FY2023 | 2023-05-08 | $-0.04 | $-0.05 | +20.0% | $40.6M | — | — | EODHD |
| Q4 FY2022 | 2023-02-21 | $-0.07 | $-0.06 | -16.7% | $36.1M | — | — | EODHD |
| Q3 FY2022 | 2022-11-07 | $-0.06 | $-0.09 | +33.3% | $32.8M | — | — | EODHD |
| Q2 FY2022 | 2022-08-08 | $-0.11 | $-0.09 | -22.2% | $18.9M | — | — | EODHD |
| Q1 FY2022 | 2022-05-04 | $-0.10 | $-0.10 | 0.0% | $12.0M | — | — | EODHD |
| Q4 FY2021 | 2022-02-23 | $-0.11 | $-0.07 | -57.1% | $12.5M | — | — | EODHD |
| Q3 FY2021 | 2021-11-08 | $-0.02 | $-0.07 | +71.4% | $22.2M | — | — | EODHD |
Source: EODHD. MNKD reported actuals as published; sparse fields render as —.
Track Record
SampleSpoken Alpha tracks MNKD's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 10/10 quarters but stock falls 60% of the time
SampleWhen a company consistently beats but the stock doesn't react, consensus is usually set too low or the buy-side number is materially above sell-side. Watch for guidance walk-downs ahead of the print.
Raised guidance 8 quarters in a row
SampleConsecutive raises tighten the bar quarter over quarter. Watch the most recent print for the magnitude of the beat — a smaller beat against a higher bar is the early signal that the regime is breaking.
Quarterly beats & misses
Sample| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $2.98 | $2.43 | +22.6% | +4.6% | +2.7% |
| Q4 FY2026 | $3.28 | $2.57 | +27.5% | -4.7% | -4.7% |
| Q3 FY2026 | $3.07 | $2.45 | +25.2% | -2.9% | -3.0% |
| Q2 FY2026 | $3.19 | $2.57 | +24.3% | -3.5% | -2.3% |
| Q1 FY2025 | $2.81 | $2.44 | +15.3% | +5.6% | +6.4% |
| Q4 FY2025 | $3.32 | $2.65 | +25.1% | +1.5% | -1.5% |
| Q3 FY2025 | $3.11 | $2.61 | +19.0% | -0.9% | -2.0% |
| Q2 FY2025 | $3.22 | $2.58 | +24.8% | -2.7% | -2.9% |
| Q1 FY2024 | $3.12 | $2.70 | +15.4% | -5.5% | -2.8% |
| Q4 FY2024 | $3.19 | $2.76 | +15.4% | +3.7% | +3.1% |
Guidance change history
Sample- Q1 FY2026Raised2026-04-15
- Q4 FY2026Raised2026-13-15
- Q3 FY2026Raised2026-10-15
- Q2 FY2026Raised2026-07-15
- Q1 FY2025Raised2025-04-15
- Q4 FY2025Raised2025-13-15
- Q3 FY2025Raised2025-10-15
- Q2 FY2025Raised2025-07-15
Top executives
SampleSpoken Alpha builds an accountability record per executive — how the person's own guidance, language, and reactions have evolved across every call they've appeared on. The one-liners below are illustrative placeholder data pending the deviation v1 work. Click any name for the full role timeline and call appearance history.
- Michael CastagnaCEO11 mo21 callsCurrentSample
CEO since 2025 • 3/4 beats (75%) • last guidance cut Q2 FY2026
- Christopher B PrentissCFO11 mo9 callsCurrentSample
CFO since 2025 • 1/4 beats (25%) • last guidance raise Q2 FY2026
- Ajay AhujaChief Medical Officer9 mono recorded callsCurrentSample
OTHER_C_SUITE since 2025 • 3/4 beats (75%) • last guidance cut Q1 FY2026
- Burkhard BlankEVP Chief Medical Officer2 yr 1 mono recorded callsCurrentSample
OTHER_C_SUITE since 2024 • 5/8 beats (63%) • guidance suspended Q2 FY2026
- Lauren M SabellaEVP Operations11 mono recorded callsCurrentSample
DIVISION_HEAD since 2025 • 3/4 beats (75%) • last guidance cut Q2 FY2026
- Sanjay R SinghEVP Technical Operations11 mono recorded callsCurrentSample
DIVISION_HEAD since 2025 • 2/4 beats (50%) • last call held guidance Q3 FY2026
Peers
Other companies in Healthcare
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
For developers and AI agents
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for MNKD.
$ curl https://api.spokenalpha.com/v1/companies/MNKDFAQ
Frequently asked about MNKD
Where can I find MANNKIND CORP's (MNKD) earnings call transcripts?
Spoken Alpha indexes MNKD's earnings call transcripts at https://spokenalpha.com/companies/MNKD. Each call links to attributed speakers and parsed analyst Q&A. MANNKIND CORP's own investor relations page is at https://investors.mannkindcorp.com/.
When was MANNKIND CORP's most recent earnings call?
MANNKIND CORP (MNKD) held its most recent earnings call on 2026-05-06, covering fiscal Q1 2026.
What sector is MNKD in?
MANNKIND CORP (MNKD) operates in the Healthcare sector (Biotechnology industry).